Cipla share price

Cipla share price - More News on LatestLY

Cipla Share Price Today, March 19: Cipla Stock Opens Higher but Slips 0.15% in Early Trade; Check Latest Price on NSE

Cipla Share Price Today, March 19: Cipla Stock Opens Higher but Slips 0.15% in Early Trade; Check Latest Price on NSE
Cipla Share Price Today, January 29: Check CIPLA Limited’s Stock Prices on NSE and BSE

Cipla Share Price Today, January 29: Check CIPLA Limited’s Stock Prices on NSE and BSE
Stocks to Buy or Sell Today, November 4, 2025: Bharti Airtel, Zydus Lifesciences, and Cipla Among Shares That May Remain in Spotlight on Tuesday

Stocks to Buy or Sell Today, November 4, 2025: Bharti Airtel, Zydus Lifesciences, and Cipla Among Shares That May Remain in Spotlight on Tuesday
Stocks To Buy or Sell Today, October 24, 2025: Tata Motors, Sagar Cements and Hero MotoCorp Among Shares That May Remain in Spotlight on Friday

Stocks To Buy or Sell Today, October 24, 2025: Tata Motors, Sagar Cements and Hero MotoCorp Among Shares That May Remain in Spotlight on Friday
Medicine Manufactured by Same Company Being Sold at 2 Different Prices by Cipla and Torrent, Claims Doctor in LinkedIn Post; Raises Question on Price Disparity

Medicine Manufactured by Same Company Being Sold at 2 Different Prices by Cipla and Torrent, Claims Doctor in LinkedIn Post; Raises Question on Price Disparity
Cipla Receives Final Approval From USFDA for Lanreotide Injection To Treat Tumours

Cipla Receives Final Approval From USFDA for Lanreotide Injection To Treat Tumours
Johnson & Johnson's Single Dose Covid-19 Vaccine Approved For Emergency Use In India

Johnson & Johnson's Single Dose Covid-19 Vaccine Approved For Emergency Use In India
India Gives Nod To Moderna mRNA Covid-19 Vaccine, Cipla To Import Under Emergency Use

India Gives Nod To Moderna mRNA Covid-19 Vaccine, Cipla To Import Under Emergency Use
Germany Sees Flash Floods As Heavy Rain And Thunderstorms Lash Southern Parts Of The Country

Germany Sees Flash Floods As Heavy Rain And Thunderstorms Lash Southern Parts Of The Country
Molnupiravir for COVID-19 Treatment: Domestic Pharma Majors Join Hands for Clinical Trial of the Oral Antiviral Drug to Treat Mild Infection

Molnupiravir for COVID-19 Treatment: Domestic Pharma Majors Join Hands for Clinical Trial of the Oral Antiviral Drug to Treat Mild Infection
Moderna COVID-19 Vaccine in India Soon as Cipla Gets DCGI Nod to Import Vaccine for Restricted Emergency Use: Sources

Moderna COVID-19 Vaccine in India Soon as Cipla Gets DCGI Nod to Import Vaccine for Restricted Emergency Use: Sources
Moderna COVID-19 Vaccine Gets Permission for Restricted Use in India

Moderna COVID-19 Vaccine Gets Permission for Restricted Use in India
Cipla Gets DCGI Nod to Import Moderna's COVID-19 Vaccine for Restricted Emergency Use in India, Say Sources

Cipla Gets DCGI Nod to Import Moderna's COVID-19 Vaccine for Restricted Emergency Use in India, Say Sources
Close to Commit Over $1-BIllion to Moderna for COVID-19 Booster Vaccine; Provide Price Capping Waiver, Indemnity: Cipla to Govt

Close to Commit Over $1-BIllion to Moderna for COVID-19 Booster Vaccine; Provide Price Capping Waiver, Indemnity: Cipla to Govt
ViraGen: Cipla Launches Real-Time COVID-19 RT-PCR Testing Kit; Here's All About The Testing Kit

ViraGen: Cipla Launches Real-Time COVID-19 RT-PCR Testing Kit; Here's All About The Testing Kit
COVID-19 Antibody Cocktail Drug Casirivimab and Imdevimab Used to Treat Donald Trump Now Launched in India at Rs 59,750 Per Dose

COVID-19 Antibody Cocktail Drug Casirivimab and Imdevimab Used to Treat Donald Trump Now Launched in India at Rs 59,750 Per Dose
Remdesivir Marketing Companies to Supply 53 Lakh Vials of Antiviral Drug for April 21 and May 16 Period to States/UTs: Govt

Remdesivir Marketing Companies to Supply 53 Lakh Vials of Antiviral Drug for April 21 and May 16 Period to States/UTs: Govt
Cipla Gets DCGI Nod to Sell Favipiravir Under Brand 'Ciplenza' to Treat Mild And Moderate COVID-19 Patients

Cipla Gets DCGI Nod to Sell Favipiravir Under Brand 'Ciplenza' to Treat Mild And Moderate COVID-19 Patients
Cipla Gets Regulatory Nod from DCGI for Launch of Ciplenza to Treat Mild to Moderate COVID-19

Cipla Gets Regulatory Nod from DCGI for Launch of Ciplenza to Treat Mild to Moderate COVID-19
Cipla Launches Generic Version Of Remdesivir In India, Aims To Supply 80000 Vials Within First Month

Cipla Launches Generic Version Of Remdesivir In India, Aims To Supply 80000 Vials Within First Month

(Know why Cipla share price is trending in Google Trends today, on January, 23 2024. Check latest news and articles on Cipla share price updated real-time on Google Trends and LatestLY)

Short Videos
Google Trends Google Trends
admit card jee mains
5000+K+ searches
copa del rey games
500+K+ searches
dow jones moneycontrol
500+K+ searches
fcb
2000+K+ searches
dow jones index
200+K+ searches
Today's Trends

Editor's Choice

Trending Topics
The Summer I Turned PrettyRepublic Day 2026Fact CheckShah Rukh KhanDonald TrumpViral VideosMaharashtra BMC ElectionsBigg Boss 19Rahul GandhiWeather Forecast TodayNarendra ModiBihar Assembly Elections 2025Kerala Lottery Results
Close